|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00460 SIHUAN PHARM
Nominal 
1.500 +0.040 (+2.740%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 243,887 | 199,487 | 46,493 | 665,293 |
| Net Cash from / (used in) Investing Activities | -- | 758,237 | 169,877 | (1,661,121) | (337,569) |
| Net Cash from / (used in) Financing Activities | -- | (1,258,407) | (419,561) | (238,934) | 750,660 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (256,283) | (50,197) | (1,853,562) | 1,078,384 |
| Cash & Cash Equivalents at beginning of period | -- | 3,778,666 | 3,828,863 | 5,682,425 | 4,604,041 |
| Effect of Foreign Exchange Rate Changes | -- | 0 | 0 | 0 | 0 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 3,522,383 | 3,778,666 | 3,828,863 | 5,682,425 |
| Remarks: | Real time quote last updated: 30/10/2025 10:21 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 102,603 |
| %Change | -- |
| EPS / (LPS) | RMB 0.011 |
| NBV Per Share (¥) | RMB 0.477 |